Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03015480 · ClinicalTrials.gov registry record · NA

Facilitating Improvements in Kidney Health Using a Smartphone App Counseling Program in Patients With Diabetes

A NA study of Diabetes Mellitus and Chronic Kidney Disease, sponsored by Geisinger Clinic.

Completed
Registry status
NA
Development phase
50
Enrollment target
2
Study locations

NCT03015480 is a NA study of Diabetes Mellitus and Chronic Kidney Disease that has completed, run by Geisinger Clinic. The registered enrollment target is 50 participants, below the 1,867-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (97% lower). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03015480, a NA study of Diabetes Mellitus and Chronic Kidney Disease, has completed, sponsored by Geisinger Clinic.

COMPLETED
Registry status
NA
Development phase
50 participants
Enrollment target
2
Study locations

Study Summary

This pilot study tests the feasibility of dietary app-supported tele-counseling in the treatment of patients with stage 1-3a chronic kidney disease (CKD) and diabetes.

Interventions

  • BEHAVIORAL Remote counseling

Study Locations (2)

Pennsylvania

  • Geisinger Medical Center - Danville
  • Geisinger Wyoming Valley Medical Center - Wilkes-Barre

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2017-02-13
Est. Completion 2018-11-25
Phase NA

Sponsor

Geisinger Clinic

107 total trials

What the Registry Record Tells You About NCT03015480

The ClinicalTrials.gov registry entry for NCT03015480 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,867-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (97% lower). The listed sponsor is Geisinger Clinic, which has 107 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Diabetes Mellitus appearing as the primary indexed condition, and to 1 intervention - of which Remote counseling is the first listed.

NCT03015480 reports 2 study locations spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT03015480 about?

NCT03015480 is a clinical study titled "Facilitating Improvements in Kidney Health Using a Smartphone App Counseling Program in Patients With Diabetes". This pilot study tests the feasibility of dietary app-supported tele-counseling in the treatment of patients with stage 1-3a chronic kidney disease (CKD) and diabetes.

What is the current status of trial NCT03015480?

This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2017-02-13. Estimated completion is 2018-11-25.

What conditions does trial NCT03015480 study?

This clinical trial studies the following conditions: Diabetes Mellitus, Chronic Kidney Disease, Albuminuria.

What interventions are being tested in trial NCT03015480?

The interventions under investigation include: Remote counseling (BEHAVIORAL).

Who is sponsoring clinical trial NCT03015480?

This trial is sponsored by Geisinger Clinic, which has 107 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03015480 being conducted?

This trial has 2 study locations across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes Mellitus

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.